片仔癀再登胡润医疗健康品牌价值榜首 老字号书写新篇章

Group 1 - The Hu Run Research Institute released the "2025 Hu Run China Brand List," expanding the number of brands from 300 to 500, with a total value of nearly 8.8 trillion yuan, an increase of 47% compared to last year [1] - The core brand "Pian Zai Huang" of Zhangzhou Pian Zai Huang Pharmaceutical Co., Ltd. ranked first in the medical health sector with a brand value of 22.5 billion yuan, marking its sixth consecutive year leading this segment [1] - The company has been promoting value upgrades through solid measures, transitioning from traditional channel operations to a new stage of deep value co-creation, and has actively expanded its product matrix while exploring diversified development paths [1] Group 2 - In 2024, the company's R&D investment reached 270 million yuan, a year-on-year increase of 16.38%, focusing on secondary development research of advantageous products like Pian Zai Huang and accelerating the development of new products such as innovative traditional Chinese medicine and classic formulas [1] - The company has established a research pipeline that includes 6 innovative traditional Chinese medicines, 6 chemical drugs, 6 ancient classic formulas, and 1 innovative biological product, with 10 new drugs entering critical clinical stages [2] - Among these, Wen Dan Pian and Chang Ji An capsules have entered Phase III clinical trials, while several other innovative traditional Chinese medicines and chemical drugs are in preclinical or pharmaceutical research stages, covering multiple therapeutic areas [2]